.jpg?format=webp&quality=80&width=3840)
This study investigates the potential of a novel artificial intelligence‐based system for autonomous follow‐up of patients treated for neovascular age‐related macular degeneration (AMD). The proposed autonomous follow‐up system was shown to be safe and compliant with expert consensus on par with clinical practice. The system could, in the future, ease the pressure on general ophthalmology services from an increasing number of AMD patients.
Like
Save
Share